 Glutamine is a major fuel for the intestinal tract and immune cells and therefore affects the intestinal permeability IP and infection rate at critically ill patients. The preferential route of glutamine supplementation at critically ill patients still remains open. Therefore the researchers will investigate IP, infection rate and treatment outcome at patients supplemented with either parenteral or enteral glutamine. 